Satoru Noguchi

Overview

Best Publications

• Guidelines for the use and interpretation of assays for monitoring autophagy

  Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  8665
  Citations

• Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy

  Satoru Noguchi;Elizabeth M. McNally;Kamel Ben Othmane;Yasuko Hagiwara

  643
  Citations

• β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex

  Carsten G. Bönnemann;Raju Modi;Satoru Noguchi;Yuji Mizuno

  553
  Citations

• From dystrophinopathy to sarcoglycanopathy: Evolution of a concept of muscular dystrophy

  Eijiro Ozawa;Satoru Noguchi;Yuji Mizuno;Yasuko Hagiwara

  335
  Citations

• Dystrophin-associated proteins in muscular dystrophy

  Eijiro Ozawa;Mikiharu Yoshida;Atsushi Suzuki;Yuji Mizuno

  334
  Citations

• Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside.

  Mikiharu Yoshida;Atsushi Suzuki;Hideko Yamamoto;Satoru Noguchi

  295
  Citations

• Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy

  Y.K. Hayashi;M. Ogawa;K. Tagawa;S. Noguchi

  293
  Citations

• Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy

  Ichizo Nishino;S. Noguchi;K. Murayama;A. Driss

  284
  Citations

• Mutations in the sarcoglycan genes in patients with myopathy.

  David J. Duggan;J. Rafael Gorospe;Marina Fanin;Eric P. Hoffman

  279
  Citations

• Autophagic degradation of nuclear components in mammalian cells.

  Young-Eun Park;Yukiko K Hayashi;Gisèle Bonne;Takuro Arimura

  245
  Citations

• Central core disease is due to RYR1 mutations in more than 90% of patients.

  Shiwen Wu;M Carlos A. Ibarra;May Christine V. Malicdan;Kumiko Murayama

  220
  Citations

• Reduction of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase activity and sialylation in distal myopathy with rimmed vacuoles.

  Satoru Noguchi;Yoko Keira;Kumiko Murayama;Megumu Ogawa

  219
  Citations

• Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model.

  May Christine V Malicdan;Satoru Noguchi;Yukiko K Hayashi;Ikuya Nonaka

  210
  Citations

• Mutations That Disrupt the Carboxyl-Terminus of γ-Sarcoglycan Cause Muscular Dystrophy

  Elizabeth M. McNally;David Duggan;J. Rafael Gorospe;Carsten G. Bönnemann

  208
  Citations

• A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy

  May Christine V. Malicdan;Satoru Noguchi;Ikuya Nonaka;Yukiko K. Hayashi

  203
  Citations

• Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness.

  Terumi Murakami;Yukiko K. Hayashi;Satoru Noguchi;Megumu Ogawa

  200
  Citations

• Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca2+ channels

  Yukari Endo;Satoru Noguchi;Yuji Hara;Yukiko K. Hayashi

  197
  Citations

• Biochemical evidence for association of dystrobrevin with the sarcoglycan–sarcospan complex as a basis for understanding sarcoglycanopathy

  Mikiharu Yoshida;Hiroshi Hama;Michiko Ishikawa-Sakurai;Michihiro Imamura

  179
  Citations

• Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing.

  Carlos A. Ibarra M;Shiwen Wu;Kumiko Murayama;Narihiro Minami

  175
  Citations

• Lysosomal myopathies: An excessive build-up in autophagosomes is too much to handle

  May Christine Malicdan;Satoru Noguchi;Ikuya Nonaka;Paul Saftig

  169
  Citations